251 286 - Biotech Bayern
251 286 - Biotech Bayern
251 286 - Biotech Bayern
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Contact:<br />
Dr. Christian Philipp<br />
Ernsbergerstr. 5A<br />
D-81241 München<br />
Phone: +49 (0) 89 5800812-0<br />
Fax: +49 (0) 89 5800812-2<br />
E-Mail: info@probior.com<br />
Internet: www.probior.com<br />
Contact:<br />
Josef-Engert-Str. 11<br />
D-93053 Regensburg<br />
Phone: +49 (0) 941 94262-0<br />
Fax: +49 (0) 941 94262-42<br />
E-Mail: info@profos.de<br />
Internet: www.profos.de<br />
Contact:<br />
Dr. Torsten Neuefeind<br />
Am Klopferspitz 19<br />
D-82152 Martinsried<br />
Phone: +49 (0) 89 700761-0<br />
Fax: +49 (0) 89 700761-15<br />
E-Mail: business@proteros.com<br />
Internet: www.proteros.com<br />
98<br />
probior GmbH<br />
BIOTECH DEVICES & REAGENTS<br />
probior offers products in the areas of biotechnology, pharmacy and medicine:<br />
special reagents for biotechnology and life science research from our partner<br />
company Dojindo (e.g. cell counting kit, DNA damage quantification kit, SOD<br />
quantification kit, etc.; overall ca. 500 reagents).<br />
Profos AG<br />
BIOTECH THERAPEUTICS & DIAGNOSTICS<br />
Keywords: Drug Development, Natural Compounds, PCR, Peptide/Protein,<br />
Infectious Diseases<br />
Profos AG, founded in 2000, employs a total of 58 permanent staff and is certified<br />
according to ISO 9001:2000 and ISO13485:2003. Profos’ core competency<br />
is to exploit the principles of bacteriophage biology for diagnostics and the<br />
combat of pathogen bacteria and bacterial toxins.<br />
Proteros biostructures GmbH<br />
BIOTECH DNA/PROTEIN ANALYTICS<br />
Keywords: 3 D Structural Analysis, Fine Chemicals / Reagents<br />
Proteros biostructures GmbH is Europe's market leading in industrial x-ray<br />
structure analysis of proteins and protein-ligand complexes for structure guided<br />
drug design. Our successful business comprises a large number of collaborations<br />
with renowned international life science companies.<br />
Proteros offers fast and reliable collaborations, with a success rate of more than<br />
90%, in important and ambitious protein structure analysis supported by unique<br />
and proprietary technologies focusing on complex structure analysis of compounds<br />
of poor solubility and/or weak affinity.<br />
In addition, Proteros has a portfolio of more than 40 pre-established structures<br />
for a range of pharmacologically relevant proteins in order to generate proteinligand<br />
structures within a few weeks.
Change language